AdvaMed To Congress: Ban Punitive Damage Awards For FDA-Cleared Items

The Senate Judiciary Committee will hold hearings in February on product liability as part of medical malpractice reform as the issue moves to the top of the White House's healthcare agenda

More from Archive

More from Medtech Insight